NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in NRX Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +2 vs. Q1 2023
- Shares held
- 9.89M
- +6.75M (+214.3%) vs. Q1 2023
- Total value
- $4.78M
- +$2.71M (+130.6%) vs. Q1 2023
- New holders
- 6
- 6 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 5,636,000 | $2.73M | 0.07% | +5,636,000 | New |
| Vanguard Group Inc | 1,478,153 | $714.7K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 699,731 | $338.3K | 1.21% | +699,731 | New |
| CVI Holdings, LLC | 483,569 | $233.8K | 0.25% | +483,569 | New |
| Geode Capital Management, LLC | 378,667 | $183.1K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 290,714 | $140.6K | 0.00% | −84,533−22.5% | Reduced |
| Royal Bank of Canada | 171,233 | $83.0K | 0.00% | +171,107+135,799.2% | Added |
| Bridgeway Capital Management, LLC | 160,700 | $77.7K | 0.00% | −70,000−30.3% | Reduced |
| State Street Corp | 114,240 | $55.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 74,996 | $36.3K | 0.00% | +3,755+5.3% | Added |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $30.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 47,326 | $22.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 43,732 | $21.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 33,500 | $16.0K | 0.00% | +8,200+32.4% | Added |
| Bank of America Corp | 30,000 | $14.5K | 0.00% | 00.0% | Unchanged |
| HBK Sorce Advisory LLC | 29,230 | $14.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 27,936 | $13.5K | 0.00% | +13,094+88.2% | Added |
| Advisor Group Holdings, Inc. | 26,150 | $12.6K | 0.00% | −1,075−3.9% | Reduced |
| Group One Trading, L.P. | 24,858 | $12.0K | 0.00% | +3,532+16.6% | Added |
| United Asset Strategies, Inc. | 18,300 | $8.85K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,052 | $7.28K | 0.00% | +15,052 | New |
| Wolverine Asset Management LLC | 10,407 | $5.03K | 0.00% | −734−6.6% | Reduced |
| Bank of New York Mellon Corp | 10,129 | $4.90K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 10,000 | $4.83K | 0.00% | +10,000 | New |
| Wells Fargo & Company | 5,340 | $2.58K | 0.00% | +31+0.6% | Added |
| UBS Group AG | 2,758 | $1.33K | 0.00% | −15,853−85.2% | Reduced |
| GWM Advisors LLC | 2,125 | $1.03K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,220 | $1.00K | 0.00% | 00.0% | Unchanged |
| Impact Partnership Wealth, LLC | 940 | $454 | 0.00% | +940 | New |
| JPMorgan Chase & Co | 339 | $164 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 247 | $119 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 218 | $105 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −80,623−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −46,210−100.0% | Sold out |
| Column Capital Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| VitalStone Financial, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |